Results 221 to 230 of about 245,551 (329)

Food Allergy and Soybean Allergen

, 2000
Tadashi Ogawa
openalex   +2 more sources

Utility of food-specific IgE concentrations in predicting symptomatic food allergy [PDF]

, 2001
Hugh A. Sampson
openalex   +1 more source

Taste Profile and Relative Bioavailability of Tovorafenib Powder for Oral Suspension and Food Effect of the Tovorafenib Tablet in Healthy Participants

Clinical Pharmacology in Drug Development, EarlyView.
Abstract A pediatric‐friendly powder for oral suspension (PfOS) of tovorafenib, a type II RAF inhibitor, was developed for patients with difficulty swallowing tablets. This open‐label, randomized, phase 1 study (QSC205140) evaluated the taste/palatability of PfOS formulations (n = 12), the relative bioavailability of the PfOS versus tablet formulation,
Yang Zhang, Mike Preigh, Jing Wang, Eleni Venetsanakos, Yujin Wang, Elly Barry, Don Corson   +6 more
wiley   +1 more source

Omalizumab in Food Allergy in Children: Current Evidence and Future Perspectives. [PDF]

Life (Basel)
Indolfi C, Perrotta A, Dinardo G, Klain A, Grella C, Palumbo P, Miraglia Del Giudice M.   +6 more
europepmc   +1 more source

444 Aspirin-dependent food allergy

, 2000
P. Schopf
openalex   +1 more source

Carrot allergy: Double-blinded, placebo-controlled food challenge and identification of allergens [PDF]

, 2001
Barbara Ballmer‐Weber, Brunello Wüthrich, Andrea Wangorsch, K. Fötisch, Friedrich Altmann, S. Vieths   +5 more
openalex   +1 more source

Evaluation of CYP2C19 Clinical Decision Support Alerts to Guide P2Y12 Inhibitor Prescribing

Clinical Pharmacology &Therapeutics, EarlyView.
P2Y12 inhibitor selection involves numerous factors, including CYP2C19 genetics, since evidence demonstrates reduced clopidogrel efficacy in patients with decreased or no function CYP2C19 variants. In 2020, Indiana University health embedded interruptive clinical decision support (CDS) alerts in the electronic health record (EHR) to recommend ...
Ashley N. Springer, Leah A. Alicea, Yemi Gafari, Tayler B. Smith, Sheryl Lynch, Amy M. Breman, Jennelle C. Hodge, Victoria M. Pratt, Nicholas R. Powell, Rolf P. Kreutz, Daniel P. Kobold, Michael T. Eadon, Emma M. Tillman, Tyler Shugg, Todd C. Skaar   +14 more
wiley   +1 more source

The Role of Omalizumab as an Adjunct to Oral Immunotherapy in Pediatric Food Allergy: A Systematic Review. [PDF]

Cureus
Khidir Mustafa AA, Elagab EA, AbdElsatar Elhagaly AM, Mohamad Ahmad Bilal AA, Mohamad Hassan DH, Ahmed Kamel AA, Ali Hassanin SH.   +6 more
europepmc   +1 more source

Gastroallergic anisakiasis: Borderline between food allergy and parasitic disease—Clinical and allergologic evaluation of 20 patients with confirmed acute parasitism by Anisakis simplex

, 2000
Álvaro Daschner, Alicia Alonso-Gómez, Rosario Cabañas, José-María Suarez-de-Parga, M C López-Serrano   +4 more
openalex   +1 more source

Predicting Maternal and Fetal Exposures of Elexacaftor–Tezacaftor–Ivacaftor during Pregnancy through Physiologically Based Pharmacokinetic Models

Clinical Pharmacology &Therapeutics, EarlyView.
The use of elexacaftor/tezacaftor/ivacaftor (ETI) has been associated with increased fertility in women with cystic fibrosis (CF) and is increasingly used during pregnancy to support both maternal and fetal health. However, little is known about the pharmacokinetics (PK) of ETI during pregnancy, which is crucial for optimizing its efficacy and safety ...
Eunjin Hong, Mary F. Hebert, Emily Fay, Grant Turner, Patricia Eshaghian, Aaron Trimble, Peter S. Chung, Adupa P. Rao, Paul M. Beringer   +8 more
wiley   +1 more source